269 related articles for article (PubMed ID: 26780991)
1. Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients.
Qiu L; Wang DR; Zhang XY; Gao S; Li XX; Sun GP; Lu XB
Transfus Apher Sci; 2016 Apr; 54(2):235-41. PubMed ID: 26780991
[TBL] [Abstract][Full Text] [Related]
2. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival.
Kwon AH; Matsui Y; Kamiyama Y
Cancer; 2001 Feb; 91(4):771-8. PubMed ID: 11241245
[TBL] [Abstract][Full Text] [Related]
3. Effects of perioperative blood transfusion on the prognosis in hereditary and sporadic colon cancer.
Li XX; Meng J; Sun GP; Tang YX; Liang GF; Wang MF; Lu XB
Biomarkers; 2015; 20(6-7):481-6. PubMed ID: 26616149
[TBL] [Abstract][Full Text] [Related]
4. The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer.
De Oliveira GS; Schink JC; Buoy C; Ahmad S; Fitzgerald PC; McCarthy RJ
Transfus Med; 2012 Apr; 22(2):97-103. PubMed ID: 22151920
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte subsets, natural killer cytotoxicity, and perioperative blood transfusion for elective colorectal cancer surgery.
Tartter PI; Martinelli G
Cancer Detect Prev Suppl; 1987; 1():571-6. PubMed ID: 3480069
[TBL] [Abstract][Full Text] [Related]
6. Impact of intraoperative allogenic and autologous transfusion on immune function and prognosis in patients with hepatocellular carcinoma.
Gong Y; Tang Y; Xue Y; Chen L
Medicine (Baltimore); 2020 Oct; 99(41):e22568. PubMed ID: 33031305
[TBL] [Abstract][Full Text] [Related]
7. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.
Heiss MM; Mempel W; Delanoff C; Jauch KW; Gabka C; Mempel M; Dieterich HJ; Eissner HJ; Schildberg FW
J Clin Oncol; 1994 Sep; 12(9):1859-67. PubMed ID: 8083709
[TBL] [Abstract][Full Text] [Related]
8. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group.
Mynster T; Christensen IJ; Moesgaard F; Nielsen HJ
Br J Surg; 2000 Nov; 87(11):1553-62. PubMed ID: 11091245
[TBL] [Abstract][Full Text] [Related]
9. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence.
van de Watering LM; Brand A; Houbiers JG; Klein Kranenbarg WM; Hermans J; van de Velde C;
Br J Surg; 2001 Feb; 88(2):267-72. PubMed ID: 11167879
[TBL] [Abstract][Full Text] [Related]
10. The impact of perioperative allogeneic blood transfusion on survival in elderly patients with colorectal cancer.
Kaneko M; Sasaki S; Ishimaru K; Terai E; Nakayama H; Watanabe T
Anticancer Res; 2015 Jun; 35(6):3553-8. PubMed ID: 26026124
[TBL] [Abstract][Full Text] [Related]
11. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.
Makino Y; Yamanoi A; Kimoto T; El-Assal ON; Kohno H; Nagasue N
Am J Gastroenterol; 2000 May; 95(5):1294-300. PubMed ID: 10811342
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer.
Qiu H; Xiao-Jun W; Zhi-Wei Z; Gong C; Guo-Qiang W; Li-Yi Z; Yuan-Fang L; Rajiv-Prasad K
Hepatogastroenterology; 2009; 56(94-95):1310-5. PubMed ID: 19950782
[TBL] [Abstract][Full Text] [Related]
13. Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients.
Chen G; Zhang FJ; Gong M; Yan M
J Zhejiang Univ Sci B; 2007 Aug; 8(8):560-5. PubMed ID: 17657857
[TBL] [Abstract][Full Text] [Related]
14. Adverse effects of perioperative blood transfusion in patients with colorectal cancer.
Jahnson S; Andersson M
Eur J Surg; 1992 Aug; 158(8):419-25. PubMed ID: 1356481
[TBL] [Abstract][Full Text] [Related]
15. Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer.
Miki C; Hiro J; Ojima E; Inoue Y; Mohri Y; Kusunoki M
Clin Oncol (R Coll Radiol); 2006 Feb; 18(1):60-6. PubMed ID: 16477921
[TBL] [Abstract][Full Text] [Related]
16. Impact of perioperative allogeneic red blood cell transfusion on recurrence and overall survival after resection of colorectal liver metastases.
Schiergens TS; Rentsch M; Kasparek MS; Frenes K; Jauch KW; Thasler WE
Dis Colon Rectum; 2015 Jan; 58(1):74-82. PubMed ID: 25489697
[TBL] [Abstract][Full Text] [Related]
17. Effects of allogeneic blood transfusion in patients with stage II colon cancer.
Meng J; Lu XB; Tang YX; Sun GP; Li X; Yan YF; Liang GF; Ma SP; Li XX
Asian Pac J Cancer Prev; 2013; 14(1):347-50. PubMed ID: 23534751
[TBL] [Abstract][Full Text] [Related]
18. Perioperative blood transfusion in cancer patients undergoing laparoscopic colorectal resection: risk factors and impact on survival.
Ghinea R; Greenberg R; White I; Sacham-Shmueli E; Mahagna H; Avital S
Tech Coloproctol; 2013 Oct; 17(5):549-54. PubMed ID: 23605190
[TBL] [Abstract][Full Text] [Related]
19. [Effect of perioperative allogenic blood transfusion on prognosis of colorectal cancer].
Zimmermann T; Dobroschke J; Borowek U; Padberg W
Zentralbl Chir; 1991; 116(19):1125-38. PubMed ID: 1759510
[TBL] [Abstract][Full Text] [Related]
20. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.
Houbiers JG; Brand A; van de Watering LM; Hermans J; Verwey PJ; Bijnen AB; Pahlplatz P; Eeftinck Schattenkerk M; Wobbes T; de Vries JE
Lancet; 1994 Aug; 344(8922):573-8. PubMed ID: 7914960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
